ORION BIOTECH OPPORTUNTES CO (ORIAU)
Institutional ownership reported to the SEC as of Q1 2023, across 8 quarters.
4
Reporting holders
$15.6M
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| JNE Partners LLP | $14.6M | 1,500,000 | 11.07% | 8q | HELD |
| Schechter Investment Advisors, LLC | $914.4K | 93,780 | 0.08% | 6q | HELD |
| 683 Capital Management, LLC | $9.8K | 1,000 | 0.00% | 8q | HELD |
| CLEAR STREET LLC | $8.3K | 850 | 0.00% | 3q | +183.3%+$5.4K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 4 | $15.6M | 1,595,630 | 0 | 1 | 0 | 0.0% |
| Q4 2022 | 5 | $15.7M | 1,611,245 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 11 | $21.0M | 2,128,585 | 2 | 1 | 3 | 0.0% |
| Q2 2022 | 11 | $30.0M | 3,048,314 | 0 | 0 | 3 | 0.0% |
| Q1 2022 | 14 | $33.2M | 3,362,356 | 1 | 0 | 5 | 0.0% |
| Q4 2021 | 18 | $56.2M | 5,698,150 | 1 | 0 | 3 | 0.0% |
| Q3 2021 | 21 | $73.8M | 7,435,183 | 1 | 3 | 7 | 0.0% |
| Q2 2021 | 43 | $148.1M | 14,713,096 | 43 | 0 | 0 | 0.0% |